Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2012

Study Completion Date

July 31, 2012

Conditions
Menopausal Syndrome
Interventions
DRUG

Micronized estradiol + progesterone

Administration of micronized estradiol + progesterone daily by a metered-dose pump during 12 weeks in postmenopausal women with no clinical evidence of cardiovascular disease.

DRUG

Nanoparticulate estradiol + progesterone

Administration of nanoparticulate estradiol + progesterone daily by a metered-dose pump during 12 weeks in postmenopausal women with no clinical evidence of cardiovascular disease.

Trial Locations (3)

59060

University Potiguar, Natal

60115-191

Gynelogical Center, Fortaleza

04023-062

Marco Botelho, São Paulo

Sponsors
All Listed Sponsors
collaborator

InBios International, Inc.

INDUSTRY

collaborator

Federal University of São Paulo

OTHER

lead

University Potiguar

OTHER

NCT02467673 - Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy | Biotech Hunter | Biotech Hunter